The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders-Reference-Cited by-同舟云学术

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders

Published:2022-02 Issue:4 Volume:179 Page:625-641
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Kruse Klausen Mette¹^ORCID,Thomsen Morgane²^ORCID,Wortwein Gitta²³^ORCID,Fink‐Jensen Anders¹²^ORCID

Affiliation:

1. Psychiatric Centre Copenhagen, Rigshospitalet, Mental Health Services, Capital Region of Denmark and University Hospital of Copenhagen Copenhagen Denmark

2. Laboratory of Neuropsychiatry Psychiatric Centre Copenhagen and University Hospital of Copenhagen Copenhagen Denmark

3. Section of Environmental Health, Department of Public Health University of Copenhagen Copenhagen Denmark

Funder

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15677

Reference150 articles.

1. Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and malignancies: A meta‐analysis based on cardiovascular outcomes trials;Abd El Aziz M.;Diabetes, Obesity and Metabolism,2020

2. Red wine enhances glucose‐dependent insulinotropic peptide (GIP) and insulin responses in type 2 diabetes during an oral glucose tolerance test;Abraham K. A.;Diabetology International,2016

3. Accumbal ghrelin and glucagon‐like peptide 1 signaling in alcohol reward in female rats;Abtahi S.;Neuroreport,2018

4. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

5. The Concise Guide to PHARMACOLOGY 2019/20: Enzymes;Alexander S. P. H.;British Journal of Pharmacology,2019

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review;European Neuropsychopharmacology;2024-10

2. Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

3. IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target;Pharmacological Research;2024-09

4. GLP-1 Receptor Agonists: Beyond Diabetes-What the Neurosurgeon Needs to Know;NEUROSURG PRACT;2024

5. Liraglutide alleviated alpha-pyrrolidinovalerophenone (α-PVP) induced cognitive deficits in rats by modifying brain mitochondrial impairment;European Journal of Pharmacology;2024-09